OVID Health is pleased to announce the return of the Patient Partnership Index 2024

About the

The Patient Partnership Index is a global initiative from the OVID Health team.

Launched in May 2020, the Index offers patient groups, pharmaceutical and biotech companies an opportunity to celebrate their patient partnerships. The aim is to showcase as many partnerships that meet the mark as possible, so we can raise the bar across the industry. Entering the Index is completely free for everyone and is seen as a vital part of reputation-building in patient engagement

The Index has a sole goal in mind: to improve patient outcomes through high quality patient-pharmaceutical partnerships in communications, advocacy, R&D, clinical trials and market access.

The concept of patient centricity is mainstream now in research and development, including in clinical trials and patient support programmes. But the Index looks beyond ‘centricity’ in R&D and into partnerships of equals for three reasons: one, because ‘centricity’ can be passive; two, it is traditionally tied to R&D; and three, because top quality communications between companies and patient groups is about collaborating as equals.

To keep up-to-date with opportunities to showcase your partnerships, register your interest.

To learn even more about how to create successful patient partnerships, you can also read our previous insights reports from 2022, 2021 and 2020.

Patient Advocacy
with OVID Health


We can work across business functions to create a ‘patient promise’ plan of action on how to embed patient-centricity in communications and advocacy.


We are experts in bringing together pharmaceutical companies and patient groups to create and deliver impactful campaigns in a range of therapy areas.

Measurement & Evaluation

Our Patient Centricity & Advocacy Tracker (PACT) is a proprietary measurement tool which companies can use to assess, track and demonstrate the quality of their patient centricity activities and, in time, anonymously benchmark themselves against competitors by producing a Patient Centricity (PACe) Score.


We can support and advise pharmaceutical companies on how to deliver truly empowered engagement programmes with healthcare professionals (particularly in rare diseases).  


We are experts in advising companies on best practice and models of convening and setting up patient advisory councils.


We can independently review your patient centricity in communications and advocacy, using the metrics developed for the Patient Partnership Index alongside bespoke support and practical advice.

Index News

As part of our continued commitment to patient partnerships here at OVID, we’re very excited to announce the launch of our new podcast series, OVIDcast: Patient Partnerships. The series will see health charity leaders speak with the OVID team about what makes for successful partnerships,......

Following the success of the Patient Partnership Index 2022, OVID Health is proud to release our insights paper which brings together the key lessons and advice from this year’s top partnerships, as well as the expert insight of senior leaders in pharma and patient advocacy,......

On Tuesday 5th July, industry leaders and patient groups came together for the third annual Patient Partnership Index event, hosted by OVID Health. At the event, judges and representatives of GOLD standard partnerships discussed key themes from this year’s entries, including addressing health inequalities, the......